Authors: van Rhijn, BWG Lurkin, I Radvanyi, F Kirkels, WJ van der Kwast, TH Zwarthoff, EC

Citation: Bwg. Van Rhijn et al., The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate, CANCER RES, 61(4), 2001, pp. 1265-1268

Authors: van Rhijn, BWG Lurkin, I Kirkels, WJ van der Kwast, TH Zwarthoff, EC

Citation: Bwg. Van Rhijn et al., Microsatellite analysis - DNA test in urine competes with cystoscopy in follow-up of superficial ladder carcinoma - A phase II trial, CANCER, 92(4), 2001, pp. 768-775

Authors: van der Poel, HG van Rhijn, BWG Peelen, P Debruyne, FMJ Boon, ME Schalken, JA

Citation: Hg. Van Der Poel et al., Consecutive quantitative cytology in bladder cancer, UROLOGY, 56(4), 2000, pp. 584-588

Authors: van Rhijn, BWG van der Poel, HG Boon, ME Debruyne, FMJ Schalken, JA Witjes, JA

Citation: Bwg. Van Rhijn et al., Presence of carcinoma in situ and high 2c-deviation index are the best predictors of invasive transitional cell carcinoma of the bladder in patients with high-risk Quanticyt, UROLOGY, 55(3), 2000, pp. 363-367